Search Count: 96
 |
Structure Of Human Endothelial Nitric Oxide Synthase Heme Domain Bound With 6-((2,3-Difluoro-5-(2-(3-Fluoroazetidin-1-Yl)Ethyl)Phenoxy)Methyl)-4-Methylpyridin-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: HEM, H4B, A1CN7, BTB, GOL, CL, GD, ZN, CA |
 |
Structure Of Human Neuronal Nitric Oxide Synthase R354A/G357D Mutant Heme Domain In Complex With 7-((3-(((4-(6-Aminopyridin-2-Yl)Butyl)Amino)Methyl)Phenoxy)Methyl)Quinolin-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: OXIDOREDUCTASE Ligands: HEM, V5D, GOL, ZN |
 |
Structure Of Human Endothelial Nitric Oxide Synthase Heme Domain In Complex With 7-((3-(((4-(6-Aminopyridin-2-Yl)Butyl)Amino)Methyl)Phenoxy)Methyl)Quinolin-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: OXIDOREDUCTASE Ligands: HEM, V5D, BTB, GOL, CL, GD, ZN |
 |
Novel Anti-Mesothelin Antibodies Enable Crystallography Of The Intact Mesothelin Ectodo- Main And Engineering Of Potent, T Cell-Engaging Bispecific Therapeutics
Organism: Mus musculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:4.31 Å Release Date: 2023-06-07 Classification: ANTITUMOR PROTEIN |
 |
Novel Anti-Mesothelin Antibodies Enable Crystallography Of The Intact Mesothelin Ectodo- Main And Engineering Of Potent, T Cell-Engaging Bispecific Therapeutics
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.38 Å Release Date: 2023-06-07 Classification: ANTITUMOR PROTEIN Ligands: NAG |
 |
Novel Anti-Mesothelin Antibodies Enable Crystallography Of The Intact Mesothelin Ectodo- Main And Engineering Of Potent, T Cell-Engaging Bispecific Therapeutics
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2023-06-07 Classification: ANTITUMOR PROTEIN Ligands: SO4 |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 16D (High Resolution)
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-07-06 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: S9U, SD6 |
 |
Organism: Leiurus quinquestriatus quinquestriatus
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-06-29 Classification: TOXIN |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 1C
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ISG |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 5C
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IS5 |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 6C
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IRZ |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 15D
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: P8L |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 16D
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: P9R |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 17D
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: P8C, PJR |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 15D
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: P8U, P8L, PG4 |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 17D
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: PJR, P8C, PG4 |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 14D
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-03-02 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IRK, IUB, PG4 |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 10D
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-02-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IRW, ITX, CL, PG4 |
 |
Structure Of Sars-Cov-2 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 13D
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-02-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IT3, ITG, PG4 |
 |
Structure Of Mers 3Cl Protease In Complex With The Cyclopropane Based Inhibitor 13C
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2022-02-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IRR, PG4 |